Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Na Ye

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Acta Pharmaceutica Sinica. B|October 24, 2025
Discovery and proof-of-concept study of a novel highly selective sigma-1 receptor agonist for antipsychotic drug developmentWanyu Tang, Zhixue Ma, Bang Li, et al.
Molecular Cancer Therapeutics|February 1, 2017
Suppression of the Growth and Invasion of Human Head and Neck Squamous Cell Carcinomas via Regulating STAT3 Signaling and the miR-21/β-catenin Axis with HJC0152Yu Wang, Sinan Wang, Yansheng Wu, et al.
Clinical Chemistry and Laboratory Medicine|November 23, 2017
Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndromeHui Shi, Hui Zheng, Yu-Feng Yin, et al.
International Journal of Laboratory Hematology|January 21, 2020
Clinical performance of automated chemiluminescent methods for anticardiolipin and anti-β2-glycoprotein I antibodies detection in a large cohort of Chinese patients with antiphospholipid syndromeLi-Yan Wan, Jie-Yu Gu, Ting-Ting Liu, et al.
Cancer Letters|November 17, 2016
Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trialsBo Yuan, Na Ye, Shan-Shan Song, et al.
Clinical and Experimental Rheumatology|October 2, 2019
Clinical features and current treatments of adult-onset Still's disease: a multicentre survey of 517 patients in ChinaQiong-Yi Hu, Ting Zeng, Chuan-Yin Sun, et al.
Clinical Rheumatology|August 21, 2018
Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohortXin-Yao Wu, Min Yang, Yue-Sheng Xie, et al.
Journal of Autoimmunity|November 10, 2020
The amino acid variants in HLA II molecules explain the major association with adult-onset Still's disease in the Han Chinese populationJia-Lin Teng, Xia Chen, Jianhua Chen, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Acta Pharmaceutica Sinica. B|October 24, 2025
Discovery and proof-of-concept study of a novel highly selective sigma-1 receptor agonist for antipsychotic drug developmentWanyu Tang, Zhixue Ma, Bang Li, et al.
Molecular Cancer Therapeutics|February 1, 2017
Suppression of the Growth and Invasion of Human Head and Neck Squamous Cell Carcinomas via Regulating STAT3 Signaling and the miR-21/β-catenin Axis with HJC0152Yu Wang, Sinan Wang, Yansheng Wu, et al.
Clinical Chemistry and Laboratory Medicine|November 23, 2017
Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndromeHui Shi, Hui Zheng, Yu-Feng Yin, et al.
International Journal of Laboratory Hematology|January 21, 2020
Clinical performance of automated chemiluminescent methods for anticardiolipin and anti-β2-glycoprotein I antibodies detection in a large cohort of Chinese patients with antiphospholipid syndromeLi-Yan Wan, Jie-Yu Gu, Ting-Ting Liu, et al.
Cancer Letters|November 17, 2016
Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trialsBo Yuan, Na Ye, Shan-Shan Song, et al.
Clinical and Experimental Rheumatology|October 2, 2019
Clinical features and current treatments of adult-onset Still's disease: a multicentre survey of 517 patients in ChinaQiong-Yi Hu, Ting Zeng, Chuan-Yin Sun, et al.
Clinical Rheumatology|August 21, 2018
Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohortXin-Yao Wu, Min Yang, Yue-Sheng Xie, et al.
Journal of Autoimmunity|November 10, 2020
The amino acid variants in HLA II molecules explain the major association with adult-onset Still's disease in the Han Chinese populationJia-Lin Teng, Xia Chen, Jianhua Chen, et al.
Pageof 13